arrow
E

Eun Joo Kang

Korea University
H指数:26
被引数:2,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes

基于组织病理学分期和EGFR分子亚型的EGFR突变非小细胞肺癌(NSCLC)的分子与临床差异

2026-03-230
PRE
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)

一项关于 tepotinib 在携带 MET 外显子 14 跳跃突变或扩增的晚期实体癌患者中的 II 期研究 (KCSG AL19-17) (第 9 卷,103668,2024)

2025-04-010
PRE
Circulating tumor DNA as a biomarker for neratinib and trastuzumab efficacy in HER2-mutated advanced solid tumors: Insights from KCSG AL20-17/KM23 phase II trial

循环肿瘤DNA作为NERATINIB和TRASTUZUMAB疗效的生物标志物:来自KCSG AL20-17/KM23 II期试验的见解

2024-09-010
PRE
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
2023-06-1215
PRE
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas

多西他赛-PM和曲妥珠单抗-pkrb联合治疗复发或转移性涎腺癌的2期多中心研究

CANCER
IF5.1
2023-05-286
PRE